Skip to main content
. 2019 Oct 15;6(5):ENEURO.0275-19.2019. doi: 10.1523/ENEURO.0275-19.2019

Table 2:

Experiment 2 statistics

Figure Statistical test Independent variable (s) Sample size Statistics Observed power Post hoc comparison (if applicable) Post hoc statistics
3 Two-way ANOVA Brain region (cortex, hypothalamus, hippocampus)Treatment (Intact + aCSF, OVX + aCSF, OVX + ICI, OVX + Let) Cortex:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 4OVX + Let n = 4Hypothalamus:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 4OVX + Let n = 4Hippocampus:Intact + aCSF n = 4OVX + aCSF n = 4OVX + ICI n = 3OVX + Let n = 4
Main effect of brain region F(2,35) = 0.031; p = 0.970 0.054
Main effect of treatment F(3,35) = 5.448; *p = 0.004 0.909 Intact + aCSF vs OVX + aCSF p = 0.527
OVX + aCSF vs OVX + ICI *p = 0.002
OVX + aCSF vs OVX + Let *p = 0.030
Brain region × treatment interaction F(6,35) = 1.015; p = 0.432 0.345

Let, Letrozole.

*Significant.